Macular Degeneration


February 20th, 2009 - February 20th, 2012
1.00 AMA PRA Category 1 Credit Hours

Description

According to the National Institutes of Health, macular degeneration, or age-related macular degeneration is a leading cause of vision loss in Americans 60 and older. It is a disease that destroys a patient’s sharp, central vision. This activity is supported in part by educational grants from Merck and Astellas.
The webcast is no longer available.
Post-Test taking for this webcast is no longer available.

Dates and Times

End Date: 2/20/2012

Objectives

Upon completion of this educational activity, the participant will be able to: 1.) Recognize signs of Dry Form of Macular Degeneration. 2.) Discuss treatment options for wet age-related macular degeneration (AMD). 3.) Review the use of photodynamic therapy in the treatment of Wet Form Macular Degeneration. 4.) Review the safety of ranibizumab in the treatment of wet age-related macular degeneration.

Webcasts Files

File Link

PDF of Slides

Download

Accreditation

The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.